Noble, Emily E.
Wang, Zhuo
Liu, Clarissa M.
Davis, Elizabeth A.
Suarez, Andrea N.
Stein, Lauren M.
Tsan, Linda
Terrill, Sarah J.
Hsu, Ted M.
Jung, A-Hyun
Raycraft, Lauren M.
Hahn, Joel D.
Darvas, Martin
Cortella, Alyssa M.
Schier, Lindsey A.
Johnson, Alexander W.
Hayes, Matthew R.
Holschneider, Daniel P.
Kanoski, Scott E.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK118000, DK118944, DK116558, DK107333, DK111475, DK118402, DK104897)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Article History
Received: 17 March 2019
Accepted: 7 October 2019
First Online: 29 October 2019
Competing interests
: M.R.H. has received research support from investigator-initiated sponsored proposals from Novo Nordisk, Zealand Pharma, and Boehringer-Ingelheim. The other authors declare no competing interests.